［1］Richardson P,Hawkey CJ,Stack WA.Proton pump inhititors［J］.Drugs,1998,56:307. ［2］Tytgat GNJ.Shortco mings of the first.generation proton pump inhibitors［J］.Eur J Gastroenterol Hapatol,2001,13(Suppl 1):s29. ［3］Sachs G,Shin JM.The Pharmacology of the gastric acid pump:The H⁺,K⁺ATPase［J］.Annu Rev Phamacol Toxicol,1995,35:277. ［4］Besancon M,Simon A,Sachs G,et al.Sites of reaction of the gastric H⁺,K⁺ ATPase with extraytoplasmic thiol regents［J］.J Biol Chen,1997,272:22438. ［5］Carswell CI,Goa KL.Rabeprazole:an update of its use in acid.related disorders［J］.Drugs,2001,61:2327. ［6］LangtryHD,Markham A.Rabeprazole:a review of its use in acid.related gastrointestinal disorders［J］.Drugs,1999,58:725. ［7］Prakash A,Faulds D.Rabeprazole［J］.Drugs,1998,55:261. ［8］Kawakami Y,Akahane T,Yamaguchi M,et al.In vitro activities of rabeprazole,a novel proton pump inhibitor and its thioether derivative alone and combination with other antimicobials against recent clinical isolates of Helicobacter pylori［J］.Antimicrob Agent Chemother,2000,44:458. ［9］孙忠实,朱珠.药物代谢性相互作用进展［J］.药物不良反应杂志,2000.1：6. ［10］Ishizaki T,Horai Y.Review article:Cytochrome P450 and the metabolism of protom pump inhibitor.emphasis on rabeprazole［J］.Aliment Pharmacol Ther,1999,13(Suppl 3):27. ［11］Johnstone D,Berger C,Fleckman P,et al.Acute ful minant hepattis after treatment with rabeprazole and tebinafine［J］.Arch Intern Med,2001,161:1677. ［12］Savarino V.抑酸治疗的新纪元［N］.中国医学论坛报.2001.09.06(4).